🚨🚨🚨
RASOLUTE-302 Ph3 is POSITIVE
"Daraxonrasib demonstrated a median OS of 13.2 months versus 6.7 months for chemotherapy, with a hazard ratio of 0.40 (p < 0.0001)".... WOW!
AMAZING news for patients with #PancreaticCancer
The RAS Revolution is ON!!
https://t.co/I59NNWRB1O
Congratulations to Dr. Nikki Lytle! Dr. Lytle received a research grant award from @RolfeFoundation for, "Pancreatic cancer metastasis prevention through precision medicine-based immune modulation!" 👏 #LeadingTheWay@mcwsurgonc
Congratulations to Dr. Nikki Lytle! Dr. Lytle recently received a @Lombardi_Fdn Research Grant for, "Therapeutic opportunities for preventing metastasis by harnessing Kupffer cells!" 👏 #LeadingTheWay@mcwsurgonc
Very interesting (albeit correlative) @CIR_AACR paper from @UW showcasing the power of dissecting cellular neighborhoods in spatial data:
Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunity
https://t.co/4sgxcIzQPF
Nice overview.
We are in an era of precision medicine. For POPF, mitigation strategies should be targeted to patients at ⬆️ risk and at the root cause.
For Whipple: leaks are contaminated, secretions are independent of hormonal signaling, and the target should be bacteria.
Two papers in @CR_AACR highlighting the unique biology of KRASG12R allele in #PancreaticCancer:
(A) weaker MAPK activation leading to greater MAPKi sensitivity
https://t.co/dBn3WaTdLt
(B) PTEN oxidation dependent (and KRAS independent) PI3K activation
https://t.co/r6BjIoHgJQ
Congrats to the 10 medical student researchers selected as winners of the Dr. Michael J. Dunn Summer Research Poster Contest!
Dr. Nikki Lytle mentored Troy Biermann and Alexander Eng who were both selected as winners! @MCWSurgery@mcwsurgonc
New in @Cancer_Cell from @MDAndersonNews colleagues @BullmanLab@CJohnstonLab1 on effects of tumor #microbiome on cancer cell cycle & chemoresistance
Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest
https://t.co/5ec0sGEh8s
The Division of Endocrine and Oncologic Surgery would like to welcome Ian W. Folkert, MD, PhD to its faculty. For more on @ianfolkert’s return to DOS, please visit:
https://t.co/Z2akjrpubl
Congratulations to Dr. @anaikothari! Dr. Kothari recently received an @ahwendowment 2025 Community-Led Momentum Grant for, "Actions to Eliminate Low Value Surgical Services and Related Health Inequities!" 👏 #LeadingTheWay@mcwsurgonc
Thrilled to see the coverage of our recent @acsJACS paper that found no evidence to support @CMSGov proposed efficiency adjustment for surgery:
https://t.co/5mqYbiYBBz
@AmerMedicalAssn
https://t.co/jsMbuwztUr
@AmCollSurgeons
https://t.co/evSUZ1EIHK
https://t.co/9OcvU69Av8
2 weeks ⏳until the 2nd Annual Selig Symposium for Surgical AI! 🤖💻
We are so excited to welcome this year’s keynote speakers 🔊@TKannampallil@DrAGonzMD
Details to register are found below👇